Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock.
Wieslaw M. Kazmierski, Gerald Wolberg, Joan G. Wilson et al. · Proceedings of the National Academy of Sciences · 1996
The hydroxamic acid siderophore ferrioxamine B [FeIII(HDFB)+] and the iron complex of diethylenetri-aminepentaacetic acid [FeIII(DTPA)2-] protected mice against death by septic shock induced by Corynebacterium parvum + lipopolysaccharide. Although FeIII(DTPA)2- was somewhat more effective than FeIII(HDFB)+, the iron-free ligand H4DFB+ was significantly more effective than DTPA. The hydroxamic acid chelator has a much higher iron affinity than the amine carboxylate, allowing for more efficient formation of the FeIII(HDFB)+ complex upon administration of the iron-free ligand. Electrochemical studies show that FeIII(DTPA)2- binds NO stoichiometrically upon reduction to iron(II) at biologically relevant potentials to form a stable NO adduct. In contrast, FeIII(HDFB)+ is a stable and efficient electrocatalyst for the reduction of NO to N2O at biologically relevant potentials. These results suggest that the mechanism of protection against death by septic shock involves NO scavenging and that particularly effective drugs that operate a low dosages may be designed based on the principle of redox catalysis. These complexes constitute a new family of drugs that rely on the special ability of transition metals to activate small molecules. In addition, the wealth of information available on siderophore chemistry and biology provides an intellectual platform for further development.
Cited by 37 works. doi:10.1073/pnas.93.17.9138
Authors
References
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
- Nitric oxide: physiology, pathophysiology, and pharmacology.
- Principles of bioinorganic chemistry
- Processing of tumour necrosis factor-α precursor by metalloproteinases
- NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
- Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
- Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
- Inflammation, immunoregulation, and inducible nitric oxide synthase